Evozyne: Engineering Biology to Solve Societal Challenges

In this interview with Insights Success, Jeff Aronin discusses Paragon Biosciences’ portfolio company Evozyne’s role in technical advancements in genetics and supercomputing in the midst of some of society’s most pressing challenges. Read more of…    Read more

Jeffrey Aronin Chairman and CEO of Paragon Biosciences

As Chairman and CEO of Paragon Biosciences, Jeffrey Aronin has invested in and launched several successful portfolio companies, including: Harmony Biosciences, Castle Creek Pharma, Emalex Biosciences, and Skyline Biosciences. Previously, Mr. Aronin served as President and CEO of…    Read more